BCIQ Profiles

Company Profile Report

First EUA for pooled COVID-19 test points to effect of prevalence on performance

FDA’s first authorization of a pooled COVID-19 test makes it clear this resource-saving approach is best reserved for populations where disease prevalence is low, highlighting the need to quickly adapt testing strategies in response to infection spikes.

The agency announced Saturday it granted Emergency Use Authorization (EUA) to Quest

Read the full 481 word article

How to gain access

Continue reading with a
two-week free trial.